Cme Group INC Form 4 insider transactions

Timothy McCourt, a Senior Managing Director at CME Group, reports acquiring and disposing of Class A Common Stock on March 15, 2025, related to performance share awards and tax obligations.

Sunil Cutinho, Chief Information Officer of CME Group, reports the acquisition of shares from a performance share award and the surrender of shares for tax obligations.

Terrence Duffy, Chairman and CEO of CME Group, reports acquiring shares from a performance share award and disposing of shares to cover tax obligations.

Hilda Harris Piell, Sr MD & Chief HR Officer at CME Group, reports acquisition of shares from a performance share award and subsequent surrender of shares to cover tax obligations.

Derek Sammann, Senior Managing Director and Global Head of Commodities Markets at CME Group, reports acquisition and disposal of company stock related to a performance share award.

Suzanne Sprague, COO & Global Head of Clearing at CME Group, reports acquisition and disposal of company stock to satisfy tax obligations related to performance share awards.

Jonathan L. Marcus, Sr MD General Counsel of CME Group Inc., surrendered 269 shares of Common Stock Class A on March 15, 2025, to cover tax obligations upon vesting of restricted stock.

Julie Winkler, Sr MD Chief Commercial Officer of CME Group, reports acquisition of 3,668 shares and disposition of 1,625 shares for tax obligations related to a performance share award.

Lynne Fitzpatrick, President and CFO of CME Group, reports acquisition and disposal of company stock to cover tax obligations and vesting of performance share awards.

Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reports acquisition and disposal of company stock related to a performance share award.

Director Howard J. Siegel sold 10,000 shares of CME Group Inc. at $260 per share on March 13, 2025.

CME Group's Chairman and CEO, Terrence A. Duffy, sold 30,000 shares of Class A common stock on March 11, 2025, at an average price of $259.18.

Suzanne Sprague, COO & Global Head of Clearing at CME Group, sold 1,500 shares of Common Stock Class A on March 3, 2025, at a price of $256.8329 per share.

Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reported a gift of 43 shares of Common Stock Class A to his adult children on February 27, 2025, resulting in a decrease in his direct holdings.

Hilda Harris Piell, Sr MD & Chief HR Officer of CME Group Inc., sold 3,984 shares of Common Stock Class A on February 27, 2025, at a price of $250.465 per share.

Ken Vroman, Chief Transformation Officer of CME Group Inc., reported the sale of 5,066 shares of Common Stock Class A on February 13, 2025.

Julie Winkler, Sr MD Chief Commercial Officer of CME Group Inc., sold 11,592 shares of Class A common stock on February 13, 2025, at an average price of $249.17.

CME Group director William R. Shepard acquired additional shares of Class A common stock through a dividend reinvestment plan.

CME Group CEO Terrence Duffy sold 11,706 shares of common stock to cover tax obligations related to the vesting of restricted stock.

Director William R. Shepard increased his holdings in CME Group through a dividend reinvestment plan, acquiring additional shares of Class A common stock.

Director Elizabeth A. Cook sold 750 shares of CME Group Inc. on November 12, 2024.

Director Martin J. Gepsman sold 400 shares of CME Group Inc. on November 4, 2024, at a price of $222.92 per share.

Sunil Cutinho, Chief Information Officer of CME Group Inc., sold 4,500 shares of Common Stock Class A at a price of $226.6397 per share on October 30, 2024.

Director Timothy S. Bitsberger of CME Group Inc. reported the sale of 1,000 shares of Common Stock Class A on October 30, 2024.

Timothy Francis McCourt, a Senior Managing Director at CME Group, sold 1,374 shares of Common Stock Class A on October 28, 2024.

Director William R. Shepard reported acquiring CME Group Inc. Class A common stock through a dividend reinvestment plan.

Lynne Fitzpatrick, CFO of CME Group, amends her Form 4 filing to correct a clerical error in the transaction code related to the surrender of shares for tax obligations and the acquisition of shares.

Suzanne Sprague, Sr MD Global Head of Clearing at CME Group, reports the acquisition and disposal of company stock.

Ken Vroman, Chief Transformation Officer of CME Group, reports the acquisition and disposal of company stock related to tax obligations and stock awards.

Sunil Cutinho, Chief Information Officer of CME Group Inc., reports the acquisition and disposal of company stock to cover tax obligations and through new acquisitions.